Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	benzodiazepine receptor binding	RIMBP3 RIMBP3C RIMBP3B	1.07e-06	5	96	3	GO:0030156
GeneOntologyMolecularFunction	glutamine N-acyltransferase activity	GLYATL1 GLYATL1B	2.29e-05	2	96	2	GO:0047946
GeneOntologyMolecularFunction	carnitine O-palmitoyltransferase activity	CPT1A CPT1B	1.36e-04	4	96	2	GO:0004095
GeneOntologyMolecularFunction	glycine N-acyltransferase activity	GLYATL1 GLYATL1B	2.27e-04	5	96	2	GO:0047961
GeneOntologyMolecularFunction	O-palmitoyltransferase activity	CPT1A CPT1B	2.27e-04	5	96	2	GO:0016416
GeneOntologyMolecularFunction	carnitine O-acyltransferase activity	CPT1A CPT1B	3.39e-04	6	96	2	GO:0016406
GeneOntologyMolecularFunction	acid phosphatase activity	ACP7 ACP3	8.06e-04	9	96	2	GO:0003993
GeneOntologyBiologicalProcess	neuromuscular synaptic transmission	RIMBP3 P2RX3 RIMBP3C RIMBP3B	2.13e-05	36	94	4	GO:0007274
GeneOntologyCellularComponent	manchette	RIMBP3 RIMBP3C RIMBP3B IQCG	8.19e-06	28	97	4	GO:0002177
GeneOntologyCellularComponent	vesicle coat	ENTHD1 EPN2 KLHL12 EPN1	2.67e-04	67	97	4	GO:0030120
GeneOntologyCellularComponent	external side of plasma membrane	SIGLEC12 ITGA11 SIGLEC9 LAG3 MUC16 MUC17 CLEC14A FCRL5 LILRB4	6.90e-04	519	97	9	GO:0009897
GeneOntologyCellularComponent	clathrin vesicle coat	ENTHD1 EPN2 EPN1	7.26e-04	38	97	3	GO:0030125
GeneOntologyCellularComponent	mitochondrial outer membrane	BCL2L10 RTN4IP1 CPT1A CPT1B GK TAFAZZIN	9.10e-04	241	97	6	GO:0005741
GeneOntologyCellularComponent	membrane coat	ENTHD1 EPN2 KLHL12 EPN1	1.51e-03	106	97	4	GO:0030117
GeneOntologyCellularComponent	coated membrane	ENTHD1 EPN2 KLHL12 EPN1	1.51e-03	106	97	4	GO:0048475
GeneOntologyCellularComponent	Golgi lumen	MUC16 MUC5B MUC17 NCAN	1.67e-03	109	97	4	GO:0005796
GeneOntologyCellularComponent	germ cell nucleus	MORC1 RFPL4AL1 RFPL4A CDK2	1.91e-03	113	97	4	GO:0043073
GeneOntologyCellularComponent	organelle outer membrane	BCL2L10 RTN4IP1 CPT1A CPT1B GK TAFAZZIN	1.92e-03	279	97	6	GO:0031968
GeneOntologyCellularComponent	outer membrane	BCL2L10 RTN4IP1 CPT1A CPT1B GK TAFAZZIN	1.99e-03	281	97	6	GO:0019867
GeneOntologyCellularComponent	clathrin coat	ENTHD1 EPN2 EPN1	2.25e-03	56	97	3	GO:0030118
Domain	Ig-like_fold	SIGLEC12 FN1 SIGLEC9 LAG3 LILRA6 DSCAML1 RIMBP3 IGSF10 TREML4 PTPRF NCAN KIR3DL3 RIMBP3C MYOM2 FCRL5 KIR2DL4 ROBO3 RIMBP3B TNXB LILRB4	1.76e-10	706	92	20	IPR013783
Domain	IG	SIGLEC12 SIGLEC9 LAG3 LILRA6 DSCAML1 IGSF10 TREML4 PTPRF NCAN KIR3DL3 MYOM2 FCRL5 KIR2DL4 ROBO3 LILRB4	2.07e-09	421	92	15	SM00409
Domain	Ig_sub	SIGLEC12 SIGLEC9 LAG3 LILRA6 DSCAML1 IGSF10 TREML4 PTPRF NCAN KIR3DL3 MYOM2 FCRL5 KIR2DL4 ROBO3 LILRB4	2.07e-09	421	92	15	IPR003599
Domain	-	SIGLEC12 FN1 SIGLEC9 LAG3 DSCAML1 RIMBP3 IGSF10 TREML4 PTPRF NCAN RIMBP3C MYOM2 FCRL5 KIR2DL4 ROBO3 RIMBP3B TNXB LILRB4	3.21e-09	663	92	18	2.60.40.10
Domain	IG_LIKE	SIGLEC12 SIGLEC9 LAG3 LILRA6 DSCAML1 IGSF10 TREML4 PTPRF NCAN KIR3DL3 MYOM2 FCRL5 KIR2DL4 ROBO3 LILRB4	1.64e-08	491	92	15	PS50835
Domain	Ig-like_dom	SIGLEC12 SIGLEC9 LAG3 LILRA6 DSCAML1 IGSF10 TREML4 PTPRF NCAN MYOM2 FCRL5 KIR2DL4 ROBO3 LILRB4	1.62e-07	503	92	14	IPR007110
Domain	ig	SIGLEC12 SIGLEC9 LAG3 LILRA6 DSCAML1 KIR3DL3 FCRL5 KIR2DL4 LILRB4	4.05e-07	190	92	9	PF00047
Domain	Immunoglobulin	SIGLEC12 SIGLEC9 LAG3 LILRA6 DSCAML1 KIR3DL3 FCRL5 KIR2DL4 LILRB4	4.05e-07	190	92	9	IPR013151
Domain	FN3	FN1 DSCAML1 RIMBP3 PTPRF RIMBP3C MYOM2 ROBO3 RIMBP3B TNXB	5.98e-07	199	92	9	PS50853
Domain	FN3_dom	FN1 DSCAML1 RIMBP3 PTPRF RIMBP3C MYOM2 ROBO3 RIMBP3B TNXB	9.02e-07	209	92	9	IPR003961
Domain	ENTH	ENTHD1 EPN2 EPN1	2.29e-06	6	92	3	PF01417
Domain	FN3	FN1 DSCAML1 PTPRF RIMBP3C MYOM2 ROBO3 RIMBP3B TNXB	3.65e-06	185	92	8	SM00060
Domain	ENTH	ENTHD1 EPN2 EPN1	9.51e-06	9	92	3	PS50942
Domain	ENTH	ENTHD1 EPN2 EPN1	9.51e-06	9	92	3	SM00273
Domain	ENTH	ENTHD1 EPN2 EPN1	1.35e-05	10	92	3	IPR013809
Domain	Ig_V-set	SIGLEC12 SIGLEC9 LAG3 DSCAML1 IGSF10 TREML4 NCAN	5.72e-05	199	92	7	IPR013106
Domain	CPT_N	CPT1A CPT1B	7.18e-05	3	92	2	IPR032476
Domain	CPT_N	CPT1A CPT1B	7.18e-05	3	92	2	PF16484
Domain	fn3	FN1 DSCAML1 PTPRF MYOM2 ROBO3 TNXB	1.50e-04	162	92	6	PF00041
Domain	IGc2	SIGLEC12 DSCAML1 IGSF10 PTPRF MYOM2 FCRL5 ROBO3	1.61e-04	235	92	7	SM00408
Domain	Ig_sub2	SIGLEC12 DSCAML1 IGSF10 PTPRF MYOM2 FCRL5 ROBO3	1.61e-04	235	92	7	IPR003598
Domain	RDM	RFPL4AL1 RFPL4A	2.38e-04	5	92	2	PF11002
Domain	RDM_domain_RFPL	RFPL4AL1 RFPL4A	2.38e-04	5	92	2	IPR022723
Domain	-	ENTHD1 EPN2 EPN1	2.77e-04	26	92	3	1.25.40.90
Domain	Ig_I-set	SIGLEC12 DSCAML1 IGSF10 PTPRF MYOM2 ROBO3	3.54e-04	190	92	6	IPR013098
Domain	I-set	SIGLEC12 DSCAML1 IGSF10 PTPRF MYOM2 ROBO3	3.54e-04	190	92	6	PF07679
Domain	ENTH_VHS	ENTHD1 EPN2 EPN1	3.85e-04	29	92	3	IPR008942
Domain	Carn_acyltransf	CPT1A CPT1B	4.96e-04	7	92	2	PF00755
Domain	ACYLTRANSF_C_1	CPT1A CPT1B	4.96e-04	7	92	2	PS00439
Domain	Carn_acyl_trans	CPT1A CPT1B	4.96e-04	7	92	2	IPR000542
Domain	ACYLTRANSF_C_2	CPT1A CPT1B	4.96e-04	7	92	2	PS00440
Domain	SH3_9	RIMBP3 RIMBP3C RIMBP3B DNMBP	5.95e-04	78	92	4	PF14604
Domain	SH3_2	RIMBP3 RIMBP3C RIMBP3B DNMBP	8.60e-04	86	92	4	IPR011511
Domain	SH3_2	RIMBP3 RIMBP3C RIMBP3B DNMBP	8.60e-04	86	92	4	PF07653
Domain	TIL	ZAN MUC5B	1.53e-03	12	92	2	PF01826
Domain	C8	ZAN MUC5B	1.53e-03	12	92	2	PF08742
Domain	EGF_1	ZAN FN1 MUC17 CLEC14A NCAN TNXB	1.64e-03	255	92	6	PS00022
Domain	Unchr_dom_Cys-rich	ZAN MUC5B	1.81e-03	13	92	2	IPR014853
Domain	C8	ZAN MUC5B	1.81e-03	13	92	2	SM00832
Domain	EGF-like_CS	ZAN FN1 MUC17 CLEC14A NCAN TNXB	1.84e-03	261	92	6	IPR013032
Domain	SEA	MUC16 MUC17	2.10e-03	14	92	2	SM00200
Domain	TIL_dom	ZAN MUC5B	2.10e-03	14	92	2	IPR002919
Domain	V-set	SIGLEC12 SIGLEC9 LAG3 TREML4 NCAN	2.16e-03	184	92	5	PF07686
Domain	-	MUC16 MUC17	2.42e-03	15	92	2	3.30.70.960
Domain	VWD	ZAN MUC5B	2.75e-03	16	92	2	SM00216
Domain	VWF_type-D	ZAN MUC5B	2.75e-03	16	92	2	IPR001846
Domain	VWFD	ZAN MUC5B	2.75e-03	16	92	2	PS51233
Domain	VWD	ZAN MUC5B	2.75e-03	16	92	2	PF00094
Domain	Kelch	KLHL5 KLHL7 KLHL12	2.93e-03	58	92	3	SM00612
Domain	BACK	KLHL5 KLHL7 KLHL12	3.23e-03	60	92	3	SM00875
Domain	BACK	KLHL5 KLHL7 KLHL12	3.39e-03	61	92	3	PF07707
Domain	BACK	KLHL5 KLHL7 KLHL12	3.39e-03	61	92	3	IPR011705
Domain	UIM	EPN2 EPN1	3.49e-03	18	92	2	PF02809
Domain	VWC_out	ZAN MUC5B	3.89e-03	19	92	2	SM00215
Domain	UIM	EPN2 EPN1	4.74e-03	21	92	2	SM00726
Domain	Kelch_1	KLHL5 KLHL7 KLHL12	4.99e-03	70	92	3	PF01344
Domain	Kelch_1	KLHL5 KLHL7 KLHL12	4.99e-03	70	92	3	IPR006652
Domain	SEA	MUC16 MUC17	5.20e-03	22	92	2	PF01390
Domain	SEA	MUC16 MUC17	5.68e-03	23	92	2	PS50024
Domain	SEA_dom	MUC16 MUC17	5.68e-03	23	92	2	IPR000082
Domain	EGF_3	ZAN MUC17 CLEC14A NCAN TNXB	6.12e-03	235	92	5	PS50026
Domain	EGF	ZAN MUC17 CLEC14A NCAN TNXB	6.12e-03	235	92	5	SM00181
Domain	UIM	EPN2 EPN1	6.17e-03	24	92	2	PS50330
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC5B MUC17	4.57e-05	16	63	3	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC5B MUC17	5.53e-05	17	63	3	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC5B MUC17	1.07e-04	21	63	3	MM15706
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC5B MUC17	1.41e-04	23	63	3	M556
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	SIGLEC12 SIGLEC9 LILRA6 TREML4 KIR2DL4 LILRB4	1.99e-04	190	63	6	M8240
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC5B MUC17	2.06e-04	26	63	3	M27483
Pathway	REACTOME_METABOLISM_OF_PORPHYRINS	SLCO2B1 COX10 UGT1A4	2.30e-04	27	63	3	M1088
Pathway	KEGG_PPAR_SIGNALING_PATHWAY	ACOX1 CPT1A CPT1B GK	2.52e-04	69	63	4	M13088
Pathway	WP_PPAR_SIGNALING_PATHWAY	ACOX1 CPT1A CPT1B GK	3.13e-04	73	63	4	MM15995
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	SIGLEC12 SIGLEC9 TREML4 KIR3DL3 KIR2DL4	3.37e-04	135	63	5	MM14781
Pathway	REACTOME_METABOLISM_OF_PORPHYRINS	SLCO2B1 COX10 UGT1A4	3.85e-04	32	63	3	MM14719
Pathway	WP_FATTY_ACID_BETAOXIDATION	CPT1A CPT1B GK	4.61e-04	34	63	3	M39596
Pathway	WP_FATTY_ACID_BETAOXIDATION	CPT1A CPT1B GK	4.61e-04	34	63	3	MM15937
Pathway	KEGG_FATTY_ACID_METABOLISM	ACOX1 CPT1A CPT1B	8.62e-04	42	63	3	M699
Pathway	WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS	ITGA11 FN1 TNXB	9.24e-04	43	63	3	M39565
Pathway	REACTOME_ASPIRIN_ADME	SLCO2B1 UGT1A4 GLYATL1	9.89e-04	44	63	3	M45014
Pathway	REACTOME_DERMATAN_SULFATE_BIOSYNTHESIS	NCAN DSEL	1.05e-03	11	63	2	M27105
Pathway	KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_ACYL_COA_SYNTHESIS	CPT1A CPT1B	1.05e-03	11	63	2	M47626
Pubmed	RIM-BP3 is a manchette-associated protein essential for spermiogenesis.	RIMBP3 RIMBP3C RIMBP3B	8.93e-08	4	99	3	19091768
Pubmed	Structure and evolution of RIM-BP genes: identification of a novel family member.	RIMBP3 RIMBP3C RIMBP3B	2.23e-07	5	99	3	17855024
Pubmed	Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library.	RIMBP3 RIMBP3C RIMBP3B	7.96e-06	14	99	3	17662146
Pubmed	Co-expression of mesothelin and CA125 correlates with unfavorable patient outcome in pancreatic ductal adenocarcinoma.	MUC16 MSLN	8.02e-06	2	99	2	21775916
Pubmed	Variants within the muscle and liver isoforms of the carnitine palmitoyltransferase I (CPT1) gene interact with fat intake to modulate indices of obesity in French-Canadians.	CPT1A CPT1B	8.02e-06	2	99	2	17089095
Pubmed	Mechanism and consequences of the duplication of the human C4/P450c21/gene X locus.	TNXA TNXB	8.02e-06	2	99	2	1373808
Pubmed	Sequences promoting the transcription of the human XA gene overlapping P450c21A correctly predict the presence of a novel, adrenal-specific, truncated form of tenascin-X.	TNXA TNXB	8.02e-06	2	99	2	8530023
Pubmed	Difference in mesothelin-binding ability of serum CA125 between patients with endometriosis and epithelial ovarian cancer.	MUC16 MSLN	8.02e-06	2	99	2	25197000
Pubmed	Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.	MUC16 MSLN	8.02e-06	2	99	2	17067392
Pubmed	A binding domain on mesothelin for CA125/MUC16.	MUC16 MSLN	8.02e-06	2	99	2	19075018
Pubmed	The sodium leak channel, NALCN, in health and disease.	NALCN UNC80	8.02e-06	2	99	2	24904279
Pubmed	Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes.	SIGLEC9 MUC16	8.02e-06	2	99	2	20497550
Pubmed	Blockade of checkpoint ILT3/LILRB4/gp49B binding to fibronectin ameliorates autoimmune disease in BXSB/Yaa mice.	FN1 LILRB4	8.02e-06	2	99	2	34089617
Pubmed	Does CA125 binding to mesothelin impact the detection of malignant mesothelioma?	MUC16 MSLN	8.02e-06	2	99	2	23357461
Pubmed	Expression and regulation of carnitine palmitoyltransferase-Ialpha and -Ibeta genes.	CPT1A CPT1B	8.02e-06	2	99	2	10408760
Pubmed	Co-Expression of Mesothelin and CA125 Is Associated with the Poor Prognosis of Endometrial Serous Carcinoma and Mixed Carcinomas Including Serous Carcinoma.	MUC16 MSLN	8.02e-06	2	99	2	32468249
Pubmed	Peptide neurotransmitters activate a cation channel complex of NALCN and UNC-80.	NALCN UNC80	8.02e-06	2	99	2	19092807
Pubmed	Significance of mesothelin and CA125 expression in endometrial carcinoma: a retrospective analysis.	MUC16 MSLN	8.02e-06	2	99	2	33832498
Pubmed	Curvature of clathrin-coated pits driven by epsin.	EPN2 EPN1	8.02e-06	2	99	2	12353027
Pubmed	UNC80 mutation causes a syndrome of hypotonia, severe intellectual disability, dyskinesia and dysmorphism, similar to that caused by mutations in its interacting cation channel NALCN.	NALCN UNC80	8.02e-06	2	99	2	26545877
Pubmed	LILRB4/gp49B Co-Localizes with Integrin via Fibronectin at Focal Adhesion Sites on Mast Cells.	FN1 LILRB4	8.02e-06	2	99	2	36642505
Pubmed	Fine chromosome mapping of the genes for human liver and muscle carnitine palmitoyltransferase I (CPT1A and CPT1B).	CPT1A CPT1B	8.02e-06	2	99	2	9070950
Pubmed	Coexpression of MUC16 and mesothelin is related to the invasion process in pancreatic ductal adenocarcinoma.	MUC16 MSLN	8.02e-06	2	99	2	22320398
Pubmed	Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis.	CPT1A CPT1B	8.02e-06	2	99	2	9013572
Pubmed	Fibronectin-LILRB4/gp49B interaction negatively regulates osteoclastogenesis through inhibition of RANKL-induced TRAF6/TAK1/NF-kB/MAPK signaling.	FN1 LILRB4	8.02e-06	2	99	2	36331874
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC16 MUC5B MUC17	1.77e-05	18	99	3	18834073
Pubmed	Epsins Negatively Regulate Aortic Endothelial Cell Function by Augmenting Inflammatory Signaling.	EPN2 EPN1	2.40e-05	3	99	2	34440686
Pubmed	Expression of tenascin in developing and adult mouse lymphoid organs.	FN1 TNXB	2.40e-05	3	99	2	7687262
Pubmed	Mutations in UNC80, Encoding Part of the UNC79-UNC80-NALCN Channel Complex, Cause Autosomal-Recessive Severe Infantile Encephalopathy.	NALCN UNC80	2.40e-05	3	99	2	26708753
Pubmed	An unequal crossover between the RCCX modules of the human MHC leading to the presence of a CYP21B gene and a tenascin TNXB/TNXA-RP2 recombinant between C4A and C4B genes in a patient with juvenile rheumatoid arthritis.	TNXA TNXB	2.40e-05	3	99	2	10343159
Pubmed	Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion.	MUC16 MSLN	2.40e-05	3	99	2	14676194
Pubmed	Genetic variants in components of the NALCN-UNC80-UNC79 ion channel complex cause a broad clinical phenotype (NALCN channelopathies).	NALCN UNC80	2.40e-05	3	99	2	30167850
Pubmed	Transcript encoded on the opposite strand of the human steroid 21-hydroxylase/complement component C4 gene locus.	TNXA TNXB	2.40e-05	3	99	2	2475872
Pubmed	DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.	MUC16 MUC5B	2.40e-05	3	99	2	27230679
Pubmed	Inhibition by etomoxir of rat liver carnitine octanoyltransferase is produced through the co-ordinate interaction with two histidine residues.	CPT1A CPT1B	2.40e-05	3	99	2	11023836
Pubmed	Genomic structure of and a cardiac promoter for the mouse carnitine palmitoyltransferase II gene.	CPT1A CPT1B	2.40e-05	3	99	2	8307575
Pubmed	A mammalian mirtron miR-1224 promotes tube-formation of human primary endothelial cells by targeting anti-angiogenic factor epsin2.	EPN2 EPN1	2.40e-05	3	99	2	28717225
Pubmed	Epsins 1 and 2 promote NEMO linear ubiquitination via LUBAC to drive breast cancer development.	EPN2 EPN1	2.40e-05	3	99	2	32960814
Pubmed	The characteristics of allelic polymorphism in killer-immunoglobulin-like receptor framework genes in African Americans.	KIR3DL3 KIR2DL4	2.40e-05	3	99	2	21607693
Pubmed	MUC5B mucin production is upregulated by fibronectin and laminin in human lung epithelial cells via the integrin and ERK dependent pathway.	FN1 MUC5B	2.40e-05	3	99	2	26057585
Pubmed	Free CA125 promotes ovarian cancer cell migration and tumor metastasis by binding Mesothelin to reduce DKK1 expression and activate the SGK3/FOXO3 pathway.	MUC16 MSLN	2.40e-05	3	99	2	33613114
Pubmed	UNC80 functions as a scaffold for Src kinases in NALCN channel function.	NALCN UNC80	2.40e-05	3	99	2	19535918
Pubmed	Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling.	EPN2 EPN1	2.40e-05	3	99	2	23187125
Pubmed	Genetic basis of tobacco smoking: strong association of a specific major histocompatibility complex haplotype on chromosome 6 with smoking behavior.	TNXA TNXB	2.40e-05	3	99	2	15339882
Pubmed	Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3.	KIR3DL3 KIR2DL4	2.40e-05	3	99	2	15778373
Pubmed	Extracellular calcium controls background current and neuronal excitability via an UNC79-UNC80-NALCN cation channel complex.	NALCN UNC80	2.40e-05	3	99	2	21040849
Pubmed	Intellectual disability-associated UNC80 mutations reveal inter-subunit interaction and dendritic function of the NALCN channel complex.	NALCN UNC80	2.40e-05	3	99	2	32620897
Pubmed	Dimerization quality control ensures neuronal development and survival.	KLHL5 KLHL7 KLHL12	4.34e-05	24	99	3	30190310
Pubmed	Immunotherapy-based targeting of MSLN+ activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis.	MUC16 MSLN	4.79e-05	4	99	2	34253615
Pubmed	Studies on the Detection, Expression, Glycosylation, Dimerization, and Ligand Binding Properties of Mouse Siglec-E.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	27920204
Pubmed	Early murine T-lymphocyte activation is accompanied by a switch from N-Glycolyl- to N-acetyl-neuraminic acid and generation of ligands for siglec-E.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	21835922
Pubmed	Human-specific elimination of epithelial Siglec-XII suppresses the risk of inflammation-driven colorectal cancers.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	38990656
Pubmed	Siglecs-7/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	34155121
Pubmed	Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity.	CPT1A CPT1B	4.79e-05	4	99	2	11095714
Pubmed	Polysialic acid and Siglec-E orchestrate negative feedback regulation of microglia activation.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	32725371
Pubmed	Genetic reduction of vascular endothelial growth factor receptor 2 rescues aberrant angiogenesis caused by epsin deficiency.	EPN2 EPN1	4.79e-05	4	99	2	24311377
Pubmed	Leishmania donovani Utilize Sialic Acids for Binding and Phagocytosis in the Macrophages through Selective Utilization of Siglecs and Impair the Innate Immune Arm.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	27494323
Pubmed	Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	37460871
Pubmed	Increased expression of carnitine palmitoyltransferase I gene is repressed by administering L-carnitine in the hearts of carnitine-deficient juvenile visceral steatosis mice.	CPT1A CPT1B	4.79e-05	4	99	2	8830050
Pubmed	Group B Streptococcus engages an inhibitory Siglec through sialic acid mimicry to blunt innate immune and inflammatory responses in vivo.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	24391502
Pubmed	Isotypic variation of novel immunoglobulin-like transcript/killer cell inhibitory receptor loci in the leukocyte receptor complex.	KIR3DL3 LILRB4	4.79e-05	4	99	2	9862332
Pubmed	The Carnitine Palmitoyl Transferase (CPT) System and Possible Relevance for Neuropsychiatric and Neurological Conditions.	CPT1A CPT1B	4.79e-05	4	99	2	26041663
Pubmed	The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	38454157
Pubmed	Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	30130255
Pubmed	Dual actions of group B Streptococcus capsular sialic acid provide resistance to platelet-mediated antimicrobial killing.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	30910970
Pubmed	O-Acetylation of Capsular Polysialic Acid Enables Escherichia coli K1 Escaping from Siglec-Mediated Innate Immunity and Lysosomal Degradation of E. coli-Containing Vacuoles in Macrophage-Like Cells.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	34878295
Pubmed	Siglec receptors impact mammalian lifespan by modulating oxidative stress.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	25846707
Pubmed	Partial duplication of chromosome 19 associated with syndromic duane retraction syndrome.	KIR3DL3 KIR2DL4	4.79e-05	4	99	2	23952617
Pubmed	Immunosuppressive Siglec-E ligands on mouse aorta are up-regulated by LPS via NF-κB pathway.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	31918287
Pubmed	Sialylated ligands on pathogenic Trypanosoma cruzi interact with Siglec-E (sialic acid-binding Ig-like lectin-E).	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	19552697
Pubmed	Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	37467314
Pubmed	Polysialic acid promotes remyelination in cerebellar slice cultures by Siglec-E-dependent modulation of microglia polarization.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	37492129
Pubmed	Ablation of Siglec-E augments brain inflammation and ischemic injury.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	35858866
Pubmed	Haplotype analysis of carnitine transporters and left ventricular mass in human essential hypertension.	CPT1A CPT1B	4.79e-05	4	99	2	15647998
Pubmed	The epsin family of endocytic adaptors promotes fibrosarcoma migration and invasion.	EPN2 EPN1	4.79e-05	4	99	2	20709745
Pubmed	The human sialic acid-binding immunoglobulin-like lectin Siglec-9 and its murine homolog Siglec-E control osteoclast activity and bone resorption.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	33007530
Pubmed	Involvement of sulfates from cruzipain, a major antigen of Trypanosoma cruzi, in the interaction with immunomodulatory molecule Siglec-E.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	26047932
Pubmed	An unequal crossover event in RCCX modules of the human MHC resulting in the formation of a TNXB/TNXA hybrid and deletion of the CYP21A.	TNXA TNXB	4.79e-05	4	99	2	12121677
Pubmed	Siglec genes confer resistance to systemic lupus erythematosus in humans and mice.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	29503442
Pubmed	Epsin-mediated degradation of IP3R1 fuels atherosclerosis.	EPN2 EPN1	4.79e-05	4	99	2	32770009
Pubmed	Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.	SIGLEC12 SIGLEC9	4.79e-05	4	99	2	25225409
Pubmed	Carnitine palmitoyltransferase-1 up-regulation by PPAR-β/δ prevents lipid-induced endothelial dysfunction.	CPT1A CPT1B	4.79e-05	4	99	2	26253087
Pubmed	The NALCN channel complex is voltage sensitive and directly modulated by extracellular calcium.	NALCN UNC80	4.79e-05	4	99	2	32494638
Pubmed	Siglec-E promotes β2-integrin-dependent NADPH oxidase activation to suppress neutrophil recruitment to the lung.	SIGLEC12 SIGLEC9	7.98e-05	5	99	2	24895121
Pubmed	Microglial CD33-related Siglec-E inhibits neurotoxicity by preventing the phagocytosis-associated oxidative burst.	SIGLEC12 SIGLEC9	7.98e-05	5	99	2	24227736
Pubmed	A soluble form of Siglec-9 provides an antitumor benefit against mammary tumor cells expressing MUC1 in transgenic mice.	SIGLEC12 SIGLEC9	7.98e-05	5	99	2	24924635
Pubmed	HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells.	KIR2DL4 LILRB4	7.98e-05	5	99	2	15670976
Pubmed	Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth.	SIGLEC12 SIGLEC9	7.98e-05	5	99	2	24045940
Pubmed	Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production.	SIGLEC12 SIGLEC9	7.98e-05	5	99	2	19933851
Pubmed	Siglec-9 modulated IL-4 responses in the macrophage cell line RAW264.	SIGLEC12 SIGLEC9	7.98e-05	5	99	2	26540411
Pubmed	Siglec-E Negatively Regulates the Activation of TLR4 by Controlling Its Endocytosis.	SIGLEC12 SIGLEC9	7.98e-05	5	99	2	27619995
Pubmed	Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis.	MUC16 MSLN	7.98e-05	5	99	2	28287406
Pubmed	Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2,8-sialyltransferase gene expression.	SIGLEC12 SIGLEC9	7.98e-05	5	99	2	16857734
Pubmed	The ret finger protein-like 4 gene, Rfpl4, encodes a putative E3 ubiquitin-protein ligase expressed in adult germ cells.	RFPL4AL1 RFPL4A	7.98e-05	5	99	2	11850190
Pubmed	Intersectin, a novel adaptor protein with two Eps15 homology and five Src homology 3 domains.	EPN2 EPN1	7.98e-05	5	99	2	9813051
Pubmed	The prognostic impact of SIGLEC5-induced impairment of CD8+ T cell activation in sepsis.	SIGLEC12 SIGLEC9	7.98e-05	5	99	2	37890368
Pubmed	A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity.	KLHL5 KLHL7 KLHL12 CDK2	1.00e-04	84	99	4	34591642
Pubmed	Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis.	ACOX1 CPT1B	1.19e-04	6	99	2	11018072
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC16 MUC5B	1.19e-04	6	99	2	19110483
Pubmed	Siglec-E is a negative regulator of acute pulmonary neutrophil inflammation and suppresses CD11b β2-integrin-dependent signaling.	SIGLEC12 SIGLEC9	1.19e-04	6	99	2	23315163
Cytoband	19q13.4	SIGLEC12 RPS5 LILRA6 KIR2DL4 LILRB4	8.36e-07	79	99	5	19q13.4
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	SIGLEC12 ACP7 SIGLEC9 RPS5 LILRA6 RFPL4AL1 RFPL4A PROSER3 KIR3DL3 KIR2DL4 EPN1 LILRB4	1.03e-05	1192	99	12	chr19q13
Cytoband	19q13.42	RFPL4AL1 RFPL4A KIR3DL3 EPN1	1.61e-04	125	99	4	19q13.42
GeneFamily	Fibronectin type III domain containing	FN1 DSCAML1 PTPRF MYOM2 ROBO3 TNXB	1.96e-05	160	63	6	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	SIGLEC12 DSCAML1 IGSF10 PTPRF MYOM2 ROBO3	2.03e-05	161	63	6	593
GeneFamily	CD molecules\|Mucins	MUC16 MUC5B MUC17	5.13e-05	21	63	3	648
GeneFamily	Kelch like\|BTB domain containing	KLHL5 KLHL7 KLHL12	4.20e-04	42	63	3	617
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	SIGLEC9 LAG3 LILRA6 KIR3DL3 FCRL5 KIR2DL4 LILRB4	4.28e-04	394	63	7	471
GeneFamily	Immunoglobulin like domain containing	LAG3 DSCAML1 MYOM2 FCRL5 ROBO3	5.60e-04	193	63	5	594
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR3DL3 KIR2DL4	1.76e-03	18	63	2	620
GeneFamily	Adenosine receptors\|V-set domain containing	SIGLEC12 SIGLEC9 TREML4 NCAN	2.51e-03	163	63	4	590
GeneFamily	CD molecules\|C2-set domain containing\|Sialic acid binding Ig like lectins	SIGLEC12 SIGLEC9	4.26e-03	28	63	2	745
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA3A CTTNBP2 MUC5B DSCAML1 KIAA1549L PIK3C2G UNC80	7.13e-08	160	99	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VWA3A CTTNBP2 MUC5B DSCAML1 KIAA1549L PIK3C2G UNC80	7.13e-08	160	99	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	TCGA-Thymus-Primary_Tumor-Thymoma-Type_C\|TCGA-Thymus / Sample_Type by Project: Shred V9	MUC16 SLC28A3 DSCAML1 KIAA1549L INPP5J MSLN	1.75e-06	163	99	6	2dac87d15051151ccf193760ddd8b82534c3f922
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	BCL2L10 MUC16 ISM2 NPFFR1 PTPRF MSLN	1.94e-06	166	99	6	4d63c758d46e73311b864148c646bf081498dee7
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|368C / Donor, Lineage, Cell class and subclass (all cells)	BCL2L10 MUC16 ISM2 NPFFR1 PTPRF MSLN	1.94e-06	166	99	6	4160ccf9291072a6e2782f9ad141bc9a9747f3ad
ToppCell	COVID-19_Mild-Neu_2\|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients	PADI4 ITGA11 IGSF10 RPUSD4 KLHL7 TAFAZZIN	2.39e-06	172	99	6	f5fd08b42c002d4693646b27e7b708eceb49524f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZAN MUC5B DSCAML1 PIK3C2G MYOM2 UNC80	3.52e-06	184	99	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZAN MUC5B DSCAML1 PIK3C2G MYOM2 UNC80	3.52e-06	184	99	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZAN MUC5B DSCAML1 PIK3C2G MYOM2 UNC80	3.52e-06	184	99	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-Macrophages\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SIGLEC9 SLCO2B1 ACP3 LAG3 LILRA6 LILRB4	4.11e-06	189	99	6	b8cbfc47f3f40b6fccd15899d58c87d07b0001aa
ToppCell	Caecum-(4)_Monocyte-(40)_Monocyte\|Caecum / shred on region, Cell_type, and subtype	SIGLEC12 PRUNE2 SIGLEC9 LILRA6 GK LILRB4	5.69e-06	200	99	6	b078058efc51f0ff4d92123b712933b32824c655
ToppCell	Caecum-(4)_Monocyte\|Caecum / shred on region, Cell_type, and subtype	SIGLEC12 PRUNE2 SIGLEC9 LILRA6 GK LILRB4	5.69e-06	200	99	6	6bfd6ab395e09087aeedc9a7c9ada1b4b8a26194
ToppCell	Caecum-Monocyte\|Caecum / Region, Cell class and subclass	SIGLEC12 PRUNE2 SIGLEC9 LILRA6 GK LILRB4	5.69e-06	200	99	6	9e8d38d024a315512521b349e8ac7caa56219daf
ToppCell	Caecum-Monocyte-Monocyte\|Caecum / Region, Cell class and subclass	SIGLEC12 PRUNE2 SIGLEC9 LILRA6 GK LILRB4	5.69e-06	200	99	6	d33619b6c721eae3ebe50fba6b9d31fa99f2248f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 CTTNBP2 MUC5B ISM2 DSCAML1	1.29e-05	135	99	5	8521107817df49efd9a2e81078c8535ed33e729c
ToppCell	facs-Trachea-nan-3m-Myeloid-granulocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 LILRA6 TREML4 NCAN LILRB4	2.07e-05	149	99	5	9c4837aa63e46382ff45a41c72beb5722b3ada19
ToppCell	facs-Brain_Myeloid-Cortex-24m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LILRA6 TREML4 FCRL5 INPP5J LILRB4	2.43e-05	154	99	5	1e088b0d4a44267f46a9b643f46a1aba784686b1
ToppCell	TCGA-Thymus-Primary_Tumor-Thymoma-Type_C-8\|TCGA-Thymus / Sample_Type by Project: Shred V9	SLC28A3 ELL3 KIAA1549L FCRL5 MSLN	2.51e-05	155	99	5	00eef9f93a753a1fe1ab5fd8dae026e7be556cde
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 APCDD1 ACP3 LILRA6 MUC5B	3.10e-05	162	99	5	dddf7a3901ae59e3494d8a6740db0fa15cc96d47
ToppCell	droplet-Lung-LUNG-30m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 APCDD1 ACP3 LILRA6 MUC5B	3.10e-05	162	99	5	2a4e09545e9874519f0f56e81065104987d81cd6
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MUC16 RFPL4A PRR35 LLGL2 GLDC	3.58e-05	167	99	5	720dc5855c856b478b5ca90156b30bfcc5518d60
ToppCell	facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CTTNBP2 FRMPD1 NPFFR1 LLGL2 PTPRF	3.58e-05	167	99	5	bebc2493a2ee41920b21c2b774a1c5a9619315c4
ToppCell	facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CTTNBP2 FRMPD1 NPFFR1 LLGL2 PTPRF	3.58e-05	167	99	5	9f2661729a2d58e17a9203a563d538c08a3dbbbc
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	BCL2L10 MUC16 ISM2 NPFFR1 MSLN	3.68e-05	168	99	5	e870d2e69316406f45112ed0bf324b24f902a99e
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	BCL2L10 MUC16 ISM2 NPFFR1 MSLN	3.68e-05	168	99	5	403aba73a0f9ffb32252288d075fad8a588ca440
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZAN APCDD1 MUC16 TNXB MSLN	4.85e-05	178	99	5	c77a1d1a9aef0ab51b4408b9e84f201219788ca2
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_8\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ACP3 ROBO3 DNMBP MSLN CDK2	4.98e-05	179	99	5	163f5430d72ea0c1b239ea5d21e53be536636d3d
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_8\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ACP3 ROBO3 DNMBP MSLN CDK2	4.98e-05	179	99	5	0624dd537a68736f4d7b8b4de2c56168ed0e60a9
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Macrophages\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SIGLEC12 SIGLEC9 SLCO2B1 LILRA6 LILRB4	5.12e-05	180	99	5	7af90f0e7ca001bf1fe5c860ee54c4cc8eb483bf
ToppCell	ICU-NoSEP-Myeloid-tDC\|ICU-NoSEP / Disease, Lineage and Cell Type	BCL2L10 SLCO2B1 IGSF10 PTPRF MSLN	5.12e-05	180	99	5	be665e801512f6aaf6b3ecb26153bbdeb24619ac
ToppCell	wk_15-18-Hematologic-Myeloid-APOE+_Mac2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	SIGLEC12 SLCO2B1 ISM2 TREML4 LILRB4	5.12e-05	180	99	5	c630a121aedd09a51ea18cc6e8552eb979e5b555
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRUNE2 CTTNBP2 FN1 NALCN TNXB	5.25e-05	181	99	5	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	10x5'-GI_large-bowel-Myeloid_Monocytic\|GI_large-bowel / Manually curated celltypes from each tissue	FN1 SIGLEC9 ACP3 LILRA6 LILRB4	6.29e-05	188	99	5	d0045fdda757d191dabc7853f6a6e99c0e97d93d
ToppCell	10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes\|GI_large-bowel / Manually curated celltypes from each tissue	FN1 SIGLEC9 ACP3 LILRA6 LILRB4	6.29e-05	188	99	5	0bcf04aa47738f43c1a87dae5dc487738ee86f8c
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Monocytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SIGLEC9 LILRA6 GK TREML4 LILRB4	6.44e-05	189	99	5	984b5f21e84dd8273d8437ac2a5a9de4e9484b9a
ToppCell	Adult\|World / Lineage, Cell type, age group and donor	SLCO2B1 TCIRG1 CPT1A GK LLGL2	6.44e-05	189	99	5	5cd285bfad973125d46d704fec18b21266a63379
ToppCell	Fetal_29-31_weeks-Immune-monocyte-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PADI4 SIGLEC9 LILRA6 GK LILRB4	6.61e-05	190	99	5	ad297172a74a80ed5c10f921e15efd1da0fd2d6b
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-D\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SIGLEC9 SLCO2B1 ACP3 GLYATL1 LILRB4	6.94e-05	192	99	5	5ea1a8119012eb8bc3100b739a0430377a8ac534
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRR35 PTPRF PIK3C2G GLDC INPP5J	6.94e-05	192	99	5	d5ec4cdb15620a5abfc83577353501186c2bc86a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRR35 PTPRF PIK3C2G GLDC INPP5J	7.11e-05	193	99	5	e7012f7b53971972299db34fa51ff51a4e4987fe
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PRR35 PTPRF PIK3C2G GLDC INPP5J	7.11e-05	193	99	5	5da60321bcf761913eb30779b6d8b1e933c5e51e
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Macrophages\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SIGLEC12 CTTNBP2 SIGLEC9 SLCO2B1 LILRB4	7.29e-05	194	99	5	7c7091de47359760003e910cfbe63db5c99410d6
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SIGLEC12 FN1 LILRA6 TCIRG1 GK	7.29e-05	194	99	5	12e42433a7b7c17c46049ef450223daf2976a59a
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	ACOX1 EPN2 LLGL2 PTPRF CLEC14A	7.29e-05	194	99	5	88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	ACOX1 EPN2 LLGL2 PTPRF CLEC14A	7.29e-05	194	99	5	a71728202493d4858342ea2756ea281cd0d99a3a
ToppCell	Parenchymal-NucSeq-Stromal-Mesofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC28A3 DSCAML1 ROBO3 TNXB MSLN	7.47e-05	195	99	5	a52685f76eca269a7d2de8dfc317439483e233fa
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-Myeloid\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SIGLEC12 CTTNBP2 SIGLEC9 SLCO2B1 LILRB4	7.47e-05	195	99	5	f289a44010788853d7726d4b5aa75f3c62186c08
ToppCell	Parenchymal-NucSeq-Stromal-Mesofibroblastic-Mesothelia\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC28A3 DSCAML1 ROBO3 TNXB MSLN	7.47e-05	195	99	5	224deeba2f60def6543a55bb4f5ee6c7fdab3f02
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SIGLEC12 SLCO2B1 NPFFR1 MUC17 LILRB4	7.65e-05	196	99	5	b15812354128c12a588d79ef449d787e74835f3b
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CCL\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SIGLEC9 ACP3 LILRA6 GK LILRB4	7.84e-05	197	99	5	61bda9b5102fdbce902bb976d1aa62f2c799d2fb
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Macrophages\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SIGLEC12 CTTNBP2 SIGLEC9 SLCO2B1 LILRB4	7.84e-05	197	99	5	e698a0bbb20bd4868ff4348f2ac9f609942b55fa
ToppCell	Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CTTNBP2 SIGLEC9 SLCO2B1 INPP5J LILRB4	8.22e-05	199	99	5	514dbf128b6832b1cbd65be023d4fe02400e8dec
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Myeloid\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CTTNBP2 SIGLEC9 SLCO2B1 LILRA6 LILRB4	8.22e-05	199	99	5	a4785c1921a3de18a9190e4d674ede6a90f80004
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SLCO2B1 LILRA6 TCIRG1 GK DNMBP	8.22e-05	199	99	5	667b8b47a5b388506e3177b46747267fad8024f6
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SIGLEC9 SLCO2B1 LILRA6 GK LILRB4	8.41e-05	200	99	5	700960201ae0df2c79e2907f5a0f95d73f8034fe
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2--L5-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	APCDD1 FRMPD1 KLHL5 GLDC INPP5J	8.41e-05	200	99	5	3cbb01039d1e7635ec4dcdf0223587f7ea3c7b34
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-OPC_related-Oligodendrocyte/OPC\|2m / Sample Type, Dataset, Time_group, and Cell type.	FN1 APCDD1 GLDC NCAN ZC3H12C	8.41e-05	200	99	5	3c9a2f02294a9fb892b89e856291bd6423ffa0a9
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-OPC_related\|2m / Sample Type, Dataset, Time_group, and Cell type.	FN1 APCDD1 GLDC NCAN ZC3H12C	8.41e-05	200	99	5	8e49e7e9b02d8411e4ffae1f5113a2c18f5bf179
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 SLC28A3 MUC5B KLHL5 PIK3C2G	8.41e-05	200	99	5	b992eeddee38e6fe3564e9b1850f6b20b89bf47d
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ITGA11 FN1 APCDD1 IGSF10 TNXB	8.41e-05	200	99	5	6f7f015b5fa1f52374f2c7d9ba339012395eda5f
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	APCDD1 FRMPD1 KLHL5 GLDC INPP5J	8.41e-05	200	99	5	97a010a1b6d551239cf6ea5a43319fb413ff180e
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	APCDD1 FRMPD1 KLHL5 GLDC INPP5J	8.41e-05	200	99	5	8ccf2dbbe34b26fbf2bbef1e64b4ae636edd6672
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ITGA11 FN1 APCDD1 IGSF10 TNXB	8.41e-05	200	99	5	3a164e3971bcd62b148b813171c103adb81f972e
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MORC1 SIGLEC9 SLCO2B1 GK LILRB4	8.41e-05	200	99	5	27f498bcd706d0751091662996795b5270e46f14
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SIGLEC9 SLCO2B1 LILRA6 RFPL4A LILRB4	8.41e-05	200	99	5	a1ae299cf77580a6d1a728ee591888b6d70a19d6
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Macrophage_other\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SIGLEC9 SLCO2B1 LILRA6 GK LILRB4	8.41e-05	200	99	5	1438b84096de9b4abe9e6213caa07f6bdff67358
ToppCell	Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Fgf10_(Lateral_dorsal_thalamic_nuclei_(LD))\|Thalamus / BrainAtlas - Mouse McCarroll V32	BCL2L10 ENTHD1 FCRL5	9.62e-05	40	99	3	c645fd6bebf8a6c5aa6ff9d40105a3d65695496b
ToppCell	(40)_Monocyte\|World / shred on Cell_type and subtype	SIGLEC9 ACP3 LILRA6 GK LILRB4	9.67e-05	206	99	5	d78a70f951265ef6df8f64404107be4f53e75d28
ToppCell	Globus_pallidus\|World / BrainAtlas - Mouse McCarroll V32	ZAN TCIRG1 DLX6 PPP6R3	1.80e-04	126	99	4	44b63f945d5bedf1a2ca1810e7e100276ea9dd89
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_B2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	ACP7 LAG3 CES4A RIMBP3C	2.03e-04	130	99	4	3709d17044d48b120effd8ba4104ca81c49d7e19
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ENTHD1 DSCAML1 GK CDK2	2.27e-04	134	99	4	0b1bb6fee8a2d8c27bca6d9cac6b47e85073dbf7
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FRMPD1 PRR35 P2RX3 PIK3C2G	2.34e-04	135	99	4	7b456fa9a5f5ce58976a8f1fad18c0f96a096930
ToppCell	PND07-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PADI4 ACP3 LILRA6 LILRB4	2.69e-04	140	99	4	90298cac4bcec614a48e60b5c139c86daa9f0321
ToppCell	PND07-Immune-Immune_Myeloid-Granulocytic-Neutrophil\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PADI4 ACP3 LILRA6 LILRB4	2.69e-04	140	99	4	671ab1f5cbd8568bf93ebdf961c2a1ede06d2bcb
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ENTHD1 PTPRF ZFP69B MSLN	2.76e-04	141	99	4	3fa3d2a8ebd9c285168ecea6db9cad74d3a3e85a
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ENTHD1 PTPRF ZFP69B MSLN	2.76e-04	141	99	4	cabb5b8c0874813c713508af2ac620ab0d61ab6f
ToppCell	PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PADI4 ITGA11 IGSF10 UNC80	2.91e-04	143	99	4	9836a040a2ebcf6f05431e658a7b8fd566621452
ToppCell	PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-Neu_2\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PADI4 ITGA11 IGSF10 UNC80	2.91e-04	143	99	4	4622c221b5d2d4cd4f37e4f81662e073924e1507
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Cyp26b1_(SNc/VTA)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ACP3 MUC17 PIK3C2G	3.39e-04	61	99	3	b3f34ed4433aa8a8a9dea9e47fb98620b4e80a6c
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Cyp26b1_(SNc/VTA)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ACP3 MUC17 PIK3C2G	3.39e-04	61	99	3	f41f1e770a5672f32cc5ccec3e33902c40f3fb1b
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CTTNBP2 ACOX1 MUC16 ELL3	3.41e-04	149	99	4	a85a051e0d82430160967e72fa04b55f43e84513
ToppCell	facs-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l8\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PADI4 LILRA6 TREML4 LILRB4	3.41e-04	149	99	4	0f9d2209e8a02371b9f93c0a2fb6f79a4ce48ef1
ToppCell	droplet-Limb_Muscle-nan-18m-Myeloid-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 LILRA6 GK LILRB4	3.49e-04	150	99	4	a003cbaf25a1b5ad4d361dcf162afe0c4b8b78f8
ToppCell	LPS-antiTNF-Endothelial-Epi-like-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VWA3A DSCAML1 KLHL5 UTP20	3.49e-04	150	99	4	9cb3332924bd67c966873343c14445e30d3f384f
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CTTNBP2 ACOX1 MUC16 ELL3	3.49e-04	150	99	4	7a381f5ae94eba5eb60dcbf83416b4eb18c279ea
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Crim1_(Neuron.Gad1Gad2.Cplx3-Crim1)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	MORC1 ZAN P2RX3	3.56e-04	62	99	3	91c49ae176d2a418a58398e9d5e55c77187cc2fb
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Crim1_(Neuron.Gad1Gad2.Cplx3-Crim1)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	MORC1 ZAN P2RX3	3.56e-04	62	99	3	3275775572a65460b6248ee72b4c85e4d4dee424
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell\|368C / Donor, Lineage, Cell class and subclass (all cells)	AKNA MYOM2 KIR2DL4 CENATAC	3.58e-04	151	99	4	512f7f37ddc8dfa1906f7fff92b571929236c9ea
ToppCell	droplet-Lung-3m-Hematologic-myeloid-neutrophil-neutrophil\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PADI4 ACP3 LILRA6 LILRB4	3.77e-04	153	99	4	ce6e462ce4dbaf9d265f1f9e2f791efbba8c1dd0
ToppCell	facs-Lung-18m-Hematologic-myeloid-leukocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TREML4 FCRL5 MSLN LILRB4	3.77e-04	153	99	4	8cc2667213bfac37545bb63181e88ef1f1834413
ToppCell	droplet-Lung-3m-Hematologic-myeloid-neutrophil\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PADI4 ACP3 LILRA6 LILRB4	3.77e-04	153	99	4	9dba38574908f31a1194b8a339868f5e4be1be71
ToppCell	facs-Lung-18m-Hematologic-myeloid-leukocyte-proliferating_myeloid_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TREML4 FCRL5 MSLN LILRB4	3.77e-04	153	99	4	596bb7cfd1c713708ce73df30d890a0233eae7f7
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ACP7 TCIRG1 PIK3C2G GLDC	3.86e-04	154	99	4	cd99428c282d566b5dbd31fd5a0371b7ffe9ffa2
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-liver_dendritic_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NPFFR1 RFPL4AL1 GLYATL1 RFPL4A	4.05e-04	156	99	4	411c170a7dd65269ae442b8069caf5231bddb116
ToppCell	facs-Liver-Hepatocytes\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FN1 SLCO2B1 PTPRF GLDC	4.05e-04	156	99	4	e2cda3ad4e5f44a80133864c5a38b766afb952ce
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ROBO3 INPP5J MSLN LILRB4	4.05e-04	156	99	4	a917b3e799a7b2a3c7f36af61f2b69292c0fb5c0
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC5B TECPR2 MSLN	4.15e-04	157	99	4	c43f2e1ea53b375a7432f17f87cfef3b2261003d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SLC28A3 PRR35 P2RX3 PIK3C2G	4.15e-04	157	99	4	2c5295043611bac7dfa4aef2146681bce4a33a8f
ToppCell	facs-Brain_Myeloid-Striatum_-18m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 ACP3 LILRA6 INPP5J	4.15e-04	157	99	4	9d4308312301cb922f156a7b6aededc9e1c62807
ToppCell	droplet-Heart-nan-18m-Myeloid\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PADI4 ACP3 LILRA6 LILRB4	4.25e-04	158	99	4	81a5a73090804d41429d297ba2462a842f39d380
Disease	peroxisomal disease (implicated_via_orthology)	ACOX1 PEX6	1.46e-04	6	93	2	DOID:906 (implicated_via_orthology)
Disease	sialic acid-binding Ig-like lectin 9 measurement	SIGLEC12 SIGLEC9	3.49e-04	9	93	2	EFO_0008286
Disease	cancer antigen 125 measurement	MUC16 MSLN	4.35e-04	10	93	2	EFO_0010603
Disease	ximenoylcarnitine (C26:1) measurement	CPT1A PPP6R3	7.49e-04	13	93	2	EFO_0800543
Disease	cerotoylcarnitine (C26) measurement	CPT1A PPP6R3	7.49e-04	13	93	2	EFO_0800542
Disease	killer cell immunoglobulin-like receptor 2DS2 measurement	KIR3DL3 KIR2DL4	1.00e-03	15	93	2	EFO_0801746
Disease	X-21441 measurement	UGT1A4 DNMBP	1.30e-03	17	93	2	EFO_0800814
Disease	response to methotrexate, juvenile idiopathic arthritis	CTTNBP2 ENTHD1	1.62e-03	19	93	2	EFO_0002609, GO_0031427
Disease	behavioural disinhibition measurement	CTTNBP2 FN1 ENTHD1	1.74e-03	75	93	3	EFO_0006946

Protein segments in the cluster

Peptide	Gene	Start	Entry
IIWAAMDSIPAPSSV	ELL3	111	Q9HB65
MADSVLSDSPGPTWG	BCL2L10	81	Q9HD36
MPLIPCLSWSTASGV	ABHD18	216	Q0P651
PASPSSWLIVVVGVM	CPT1A	56	P50416
APVLDITTWTFPIMA	COX10	371	Q12887
RSPGVEWEMPLATDS	DNMBP	386	Q6XZF7
EWEMPLATDSPTSDP	DNMBP	391	Q6XZF7
VWDVSASAKGVSMPP	DLX6	136	P56179
VDWPESSLAMSPGEE	ECD	371	O95905
WHSEMTVSVTGEPPS	IQCG	16	Q9H095
WILTEPSTIATVMVP	MUC5B	4846	Q9HC84
MWATVPSSPTLDRDT	RIMBP3B	791	A6NNM3
MWATVPSSPTLDRDT	RIMBP3C	791	A6NJZ7
EMITPGVWDVSQPSP	PIK3C2G	606	O75747
EESLSEVVVPMPSWL	MORC1	136	Q86VD1
GEPGSMTVTWTTWVP	ACP7	41	Q6ZNF0
CMPTTLVDNLITGWP	NPFFR1	96	Q9GZQ6
STWPLDPGVEVTLTM	PADI4	66	Q9UM07
SNDPWGPSSSLMLDI	ENTHD1	26	Q8IYW4
APSEQTTITLPMATW	MUC16	1446	Q8WXI7
PTPSMEVTPWISLTL	MUC16	1821	Q8WXI7
NSPWKTPETTVPMET	MUC16	3226	Q8WXI7
STMEWPIDGGTSLTP	LLGL2	416	Q6P1M3
WSQPSDPLELVMTGA	LILRB4	106	Q8NHJ6
DPWGPSSSLMTEIAD	EPN2	31	O95208
INPSIPSIWTAVSGM	LMO7DN	31	F2Z398
MEHVTEGSWESLPVP	DDX55	1	Q8NHQ9
WTVTEPAAMTPGNAT	ISM2	81	Q6H9L7
EVPWGSSPARMSSAV	PNMA6E	576	A0A0J9YXQ4
DMPLWSSSTPSVGRV	FCRL5	511	Q96RD9
MVGSTLSPVPWLPSE	PEX6	411	Q13608
PENLIPMWSSDIVTG	NEK4	421	P51957
PEEIIWSMSPVVDGV	CES4A	311	Q5XG92
WSMSPVVDGVVIPDD	CES4A	316	Q5XG92
WSAPSNPVVIMVTGV	KIR3DL3	106	Q8N743
VPVSWVTMDPSCEVG	GLYATL1	216	Q969I3
PPSTWSVSTMDALRG	MSLN	236	Q13421
PATETWTELCPMIEA	KLHL7	456	Q8IXQ5
PDGSPSWSMLEVASG	KIAA1549L	71	Q6ZVL6
MTASPPGSLRASDWV	LAG3	171	P18627
WSEPSDPLELVMTGF	LILRA6	106	Q6PI73
PMLDDGWPTTLRVSV	ITGA11	761	Q9UKX5
VFAASTVPMTPLWVS	RFPL4A	196	A6NLU0
PSWPMASTSEVPAFE	KLHL5	126	Q96PQ7
SLPTGSSVMLWPEDG	PRR35	361	P0CG20
TEWSAPSNPLVIMVT	KIR2DL4	106	Q99706
GPVIPQDWSTECMTT	ACP3	361	P15309
WPTMVDINSPESLTE	ACOX1	471	Q15067
PVPEISWSLPDGTMI	IGSF10	2066	Q6WRI0
DPIIDSWEVVTSMGT	KLHL12	541	Q53G59
VTASGWSPSLTPLLM	CTTNBP2	686	Q8WZ74
PCVVSSGDMPIRITW	DSCAML1	616	Q8TD84
VKVTIMWTPPESAVT	FN1	921	P02751
GWTEAQPSSMLEPLA	FRMPD1	741	Q5SYB0
VPVSWVTMDPSCEIG	GLYATL1B	216	A0A0U1RQE8
SMGWVTTQSPESGDP	GK	516	P32189
SSLTSMPTLGWLPEN	AKNA	536	Q7Z591
TVQMPPTIEGHWVST	APCDD1	66	Q8J025
DPWGPSSSLMSEIAD	EPN1	31	Q9Y6I3
PELDWMETGPSLTFI	CENATAC	211	Q86UT8
TPDEVVWPGVTSMPD	CDK2	221	P24941
DGPMVPSTAQRWSTL	DSEL	371	Q8IZU8
DCPQWMVPITISTSE	NPEPPS	536	P55786
PGSPTSWLVVIMATV	CPT1B	56	Q92523
SVTGTPYWMSPEVIS	MAP3K3	526	Q99759
GWCPTEVDTVETPIM	P2RX3	151	P56373
SASTMLVQWEPPEEP	PTPRF	426	P10586
VSMGSTTVRVSWVPP	PTPRF	616	P10586
IWTPSEGSTPLTTMP	MUC17	3686	Q685J3
WAITVHVPMPSAGVV	RPUSD4	186	Q96CM3
TSPRSTVMPAWVIDK	RTN4IP1	36	Q8WWV3
MTEWETAAPAVAETP	RPS5	1	P46782
PVTETETQLPWMLIG	UTP20	256	O75691
VFAASTVPMTPLWVS	RFPL4AL1	196	F8VTS6
PWTFSPLTETEMQIT	PRUNE2	1766	Q8WUY3
MWATVPSSPTLDRDT	RIMBP3	791	Q9UFD9
VWLSTVAPSPSDMGA	NCAN	446	O14594
EQGTPPMISWIGTSV	SIGLEC9	171	Q9Y336
PMISWIGTSVSPLDP	SIGLEC9	176	Q9Y336
TTEGQMWASPAPTLI	PROSER3	81	Q2NL68
MWASPAPTLIDSGDS	PROSER3	86	Q2NL68
GWIMLVTTGSSPIES	SLC28A3	316	Q9HAS3
QGTPPTITWMGASVS	SIGLEC12	301	Q96PQ1
TSIPEIPRWGSQSTM	CLEC14A	341	Q86T13
TVVTWNVGTAMPPDD	INPP5J	426	Q15735
TVLSPGFTEVMPWQS	TOP3B	446	O95985
PWSASEPSIEPEGMS	UNC80	1431	Q8N2C7
SLVVSPAPTTSPMWT	TREML4	126	Q6UXN2
EEPLTVWMASFSPVS	VCX2	121	Q9H322
AVPPLTWTLASSVVM	TAFAZZIN	11	Q16635
WMPSPVIHGSAIDTT	SLCO2B1	611	O94956
PEGGSWTMLDLQSPS	ROBO3	711	Q96MS0
TPDSLSLSWMVPEGQ	TNXB	2856	P22105
ATPDSLSLSWMVPEG	TNXB	3071	P22105
ITEEMPVGTAWEHVP	TECPR2	1296	O15040
TPDSMRLSWSVAQGP	TNXA	56	Q16473
EPWLMERDISGVPSS	ZFP69B	131	Q9UJL9
PAVPWSTVENPSMDT	ZC3H12C	56	Q9C0D7
SVGSDVWSTEEPMPT	PPP6R3	701	Q5H9R7
EPVSSWFGPGSVLMS	TMX1	136	Q9H3N1
AGSLWPDPMEVSAST	VWA3A	216	A6NCI4
AFGSTIESWRPEMVP	VWA3A	551	A6NCI4
EHPVTGEPATWMTFL	TCIRG1	206	Q13488
RPSWMLTTVTVPAGF	ZAN	156	Q9Y493
VLVVPTDGSPWLSMR	UGT1A4	31	P22310
SWPVAGTLMVEPTES	GLDC	896	P23378
WDVEDPVTVPLATMS	NALCN	1231	Q8IZF0
VTWKPPNTTTESPVM	MYOM2	401	P54296